FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
16
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
2:02
WFTX
1 year agoTeachers fight for higher pay amid teacher shortage
6851 -
0:42
KMGH
2 years agoBBB warns about travel scams
55 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
52 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:57:57
The Charlie Kirk Show
3 hours agoFulfill The Mandate | Paoletta, Schilling, Schlicther | 11.11.24
175K68 -
1:23:15
The New American
2 hours agoTrump to End Censorship | The New American Daily
13.1K -
1:09:22
The Kevin Trudeau Show
5 hours agoThe Kevin Trudeau Show | Ep. 64 | LIVE at 1 PM CT
11.3K1